NO342822B1 - Vaksine som induserer en immunrespons mot kopepoder og/eller et slimskjold hos fisk omfattende peptidkombinasjoner, og anvendelse av peptidene for fremstilling av en vaksine. - Google Patents
Vaksine som induserer en immunrespons mot kopepoder og/eller et slimskjold hos fisk omfattende peptidkombinasjoner, og anvendelse av peptidene for fremstilling av en vaksine. Download PDFInfo
- Publication number
- NO342822B1 NO342822B1 NO20141508A NO20141508A NO342822B1 NO 342822 B1 NO342822 B1 NO 342822B1 NO 20141508 A NO20141508 A NO 20141508A NO 20141508 A NO20141508 A NO 20141508A NO 342822 B1 NO342822 B1 NO 342822B1
- Authority
- NO
- Norway
- Prior art keywords
- caligus
- seq
- vaccine
- fish
- peptides
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title claims abstract description 129
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 85
- 241000251468 Actinopterygii Species 0.000 title claims abstract description 84
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 55
- 241000239250 Copepoda Species 0.000 title claims abstract description 23
- 230000028993 immune response Effects 0.000 title claims abstract description 14
- 210000003097 mucus Anatomy 0.000 title claims description 33
- 230000001939 inductive effect Effects 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 38
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 38
- 230000000890 antigenic effect Effects 0.000 claims abstract description 8
- 235000019688 fish Nutrition 0.000 claims description 85
- 239000000203 mixture Substances 0.000 claims description 26
- 239000002671 adjuvant Substances 0.000 claims description 18
- 108060003552 hemocyanin Proteins 0.000 claims description 17
- 241000542855 Megathura crenulata Species 0.000 claims description 16
- 239000002480 mineral oil Substances 0.000 claims description 15
- 235000010446 mineral oil Nutrition 0.000 claims description 15
- 239000000839 emulsion Substances 0.000 claims description 14
- 241000277263 Salmo Species 0.000 claims description 12
- 241000277275 Oncorhynchus mykiss Species 0.000 claims description 10
- 241000277338 Oncorhynchus kisutch Species 0.000 claims description 8
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 7
- 241001280377 Oncorhynchus tshawytscha Species 0.000 claims description 6
- 241000277288 Salmo trutta Species 0.000 claims description 6
- 238000011161 development Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 241001247232 Caligidae Species 0.000 claims description 5
- 241000277289 Salmo salar Species 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 7
- 241001611011 Caligus Species 0.000 description 192
- 235000018102 proteins Nutrition 0.000 description 34
- 244000045947 parasite Species 0.000 description 21
- 239000003921 oil Substances 0.000 description 20
- 238000002255 vaccination Methods 0.000 description 20
- 241001611004 Caligus rogercresseyi Species 0.000 description 19
- 230000003053 immunization Effects 0.000 description 19
- 238000002649 immunization Methods 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 17
- 241001247234 Lepeophtheirus salmonis Species 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 206010061217 Infestation Diseases 0.000 description 15
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 13
- 230000009467 reduction Effects 0.000 description 13
- 210000002966 serum Anatomy 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 12
- 235000018417 cysteine Nutrition 0.000 description 12
- 230000003248 secreting effect Effects 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 9
- 241000972773 Aulopiformes Species 0.000 description 8
- 241000237858 Gastropoda Species 0.000 description 8
- 241000277331 Salmonidae Species 0.000 description 8
- 101710161198 Vitellogenin-1 Proteins 0.000 description 8
- 150000001413 amino acids Chemical group 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 7
- 230000000366 juvenile effect Effects 0.000 description 7
- 235000019515 salmon Nutrition 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 241000239267 Arguloida Species 0.000 description 5
- 241000237988 Patellidae Species 0.000 description 5
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 5
- 108010090932 Vitellogenins Proteins 0.000 description 5
- 238000003776 cleavage reaction Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 229920002401 polyacrylamide Polymers 0.000 description 5
- 230000007017 scission Effects 0.000 description 5
- 238000002965 ELISA Methods 0.000 description 4
- 101710161186 Vitellogenin-2 Proteins 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- 230000002596 correlated effect Effects 0.000 description 4
- 210000002615 epidermis Anatomy 0.000 description 4
- 230000002163 immunogen Effects 0.000 description 4
- 108010045069 keyhole-limpet hemocyanin Proteins 0.000 description 4
- 230000003071 parasitic effect Effects 0.000 description 4
- 239000013535 sea water Substances 0.000 description 4
- 239000007790 solid phase Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- 241001247233 Lepeophtheirus Species 0.000 description 3
- 241000607479 Yersinia pestis Species 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 239000011324 bead Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 210000000981 epithelium Anatomy 0.000 description 3
- 230000001524 infective effect Effects 0.000 description 3
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 3
- 210000003491 skin Anatomy 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 206010022095 Injection Site reaction Diseases 0.000 description 2
- 241000873862 Paracyclopina nana Species 0.000 description 2
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
- 241000238680 Rhipicephalus microplus Species 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 238000005273 aeration Methods 0.000 description 2
- 230000005875 antibody response Effects 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 238000009360 aquaculture Methods 0.000 description 2
- 244000144974 aquaculture Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229960005274 benzocaine Drugs 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 244000078703 ectoparasite Species 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000000091 immunopotentiator Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 208000028454 lice infestation Diseases 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229940035032 monophosphoryl lipid a Drugs 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 108010004034 stable plasma protein solution Proteins 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 239000012646 vaccine adjuvant Substances 0.000 description 2
- 229940124931 vaccine adjuvant Drugs 0.000 description 2
- LLXVXPPXELIDGQ-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 3-(2,5-dioxopyrrol-1-yl)benzoate Chemical compound C=1C=CC(N2C(C=CC2=O)=O)=CC=1C(=O)ON1C(=O)CCC1=O LLXVXPPXELIDGQ-UHFFFAOYSA-N 0.000 description 1
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 1
- VZQHRKZCAZCACO-PYJNHQTQSA-N (2s)-2-[[(2s)-2-[2-[[(2s)-2-[[(2s)-2-amino-5-(diaminomethylideneamino)pentanoyl]amino]propanoyl]amino]prop-2-enoylamino]-3-methylbutanoyl]amino]propanoic acid Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)C(=C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(N)=N VZQHRKZCAZCACO-PYJNHQTQSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 241000704622 Antennatus Species 0.000 description 1
- 241000402794 Argulus foliaceus Species 0.000 description 1
- 231100000699 Bacterial toxin Toxicity 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
- 241000571350 Caligus aesopus Species 0.000 description 1
- 241001235711 Caligus centrodonti Species 0.000 description 1
- 241000420702 Caligus cheilodactyli Species 0.000 description 1
- 241000571348 Caligus chorinemi Species 0.000 description 1
- 241000712786 Caligus clemensi Species 0.000 description 1
- 241000571346 Caligus confusus Species 0.000 description 1
- 241001235719 Caligus curtus Species 0.000 description 1
- 241001382015 Caligus diaphanus Species 0.000 description 1
- 241001405819 Caligus elongatus Species 0.000 description 1
- 241000109841 Caligus fugu Species 0.000 description 1
- 241001235713 Caligus gurnardi Species 0.000 description 1
- 241000571427 Caligus hoplognathi Species 0.000 description 1
- 241001325422 Caligus longirostris Species 0.000 description 1
- 241000571430 Caligus mutabilis Species 0.000 description 1
- 241001155277 Caligus punctatus Species 0.000 description 1
- 241001382014 Caligus quadratus Species 0.000 description 1
- 241000571422 Caligus robustus Species 0.000 description 1
- 241000571424 Caligus sclerotinosus Species 0.000 description 1
- 241000571399 Caligus serratus Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108010039939 Cell Wall Skeleton Proteins 0.000 description 1
- 241001436044 Chelifer Species 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 102000009016 Cholera Toxin Human genes 0.000 description 1
- 108010049048 Cholera Toxin Proteins 0.000 description 1
- 241000522241 Cordyla <angiosperm> Species 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 101710146739 Enterotoxin Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108010040721 Flagellin Proteins 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 238000012313 Kruskal-Wallis test Methods 0.000 description 1
- 241001235686 Lepeophtheirus pectoralis Species 0.000 description 1
- 241001382017 Lepeophtheirus thompsoni Species 0.000 description 1
- 241001401881 Longicaudus Species 0.000 description 1
- 241000781273 Longipedis Species 0.000 description 1
- 206010062049 Lymphocytic infiltration Diseases 0.000 description 1
- 241000972747 Macrourus Species 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- -1 N-protected amino Chemical group 0.000 description 1
- 241000737052 Naso hexacanthus Species 0.000 description 1
- 241000123077 Ocyurus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 101710176384 Peptide 1 Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 241000882917 Pomacentrus Species 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 241001098657 Pterois Species 0.000 description 1
- 241000353093 Raniceps Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000306752 Salmoneus Species 0.000 description 1
- 241001194796 Schistonyx Species 0.000 description 1
- 241001290310 Sciaenops Species 0.000 description 1
- 241001187507 Sicarius Species 0.000 description 1
- 108010008038 Synthetic Vaccines Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241000045687 Tigriopus japonicus Species 0.000 description 1
- 241000607598 Vibrio Species 0.000 description 1
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- ZCHPKWUIAASXPV-UHFFFAOYSA-N acetic acid;methanol Chemical compound OC.CC(O)=O ZCHPKWUIAASXPV-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000000688 bacterial toxin Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000005587 bubbling Effects 0.000 description 1
- FVMOEFABYNPCDS-UHFFFAOYSA-L calcium;1-(4-carboxy-2,6-dioxocyclohexylidene)propan-1-olate Chemical compound [Ca+2].CCC([O-])=C1C(=O)CC(C(O)=O)CC1=O.CCC([O-])=C1C(=O)CC(C(O)=O)CC1=O FVMOEFABYNPCDS-UHFFFAOYSA-L 0.000 description 1
- 210000004520 cell wall skeleton Anatomy 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 239000000147 enterotoxin Substances 0.000 description 1
- 231100000655 enterotoxin Toxicity 0.000 description 1
- 230000003628 erosive effect Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 210000002175 goblet cell Anatomy 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 description 1
- 229960002751 imiquimod Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000001759 immunoprophylactic effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000015788 innate immune response Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- GZQKNULLWNGMCW-PWQABINMSA-N lipid A (E. coli) Chemical class O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](OP(O)(O)=O)O1 GZQKNULLWNGMCW-PWQABINMSA-N 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229940046166 oligodeoxynucleotide Drugs 0.000 description 1
- 230000000426 osmoregulatory effect Effects 0.000 description 1
- 230000036281 parasite infection Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 229940023041 peptide vaccine Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 229940124551 recombinant vaccine Drugs 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 210000002955 secretory cell Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 239000000277 virosome Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Wood Science & Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2012/052487 WO2013171548A2 (es) | 2012-05-17 | 2012-05-17 | Peptidos que inducen en peces una respuesta inmune contra copepodos y/o un escudo mucoso, vacunas, usos y métodos para modular la respuesta inmune de un pez y/o inducir la generación de un escudo mucoso |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20141508A1 NO20141508A1 (no) | 2015-02-05 |
| NO342822B1 true NO342822B1 (no) | 2018-08-13 |
Family
ID=49584397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20141508A NO342822B1 (no) | 2012-05-17 | 2014-12-12 | Vaksine som induserer en immunrespons mot kopepoder og/eller et slimskjold hos fisk omfattende peptidkombinasjoner, og anvendelse av peptidene for fremstilling av en vaksine. |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR092320A1 (es) |
| CA (1) | CA2873599A1 (es) |
| GB (1) | GB2522119A (es) |
| NO (1) | NO342822B1 (es) |
| WO (1) | WO2013171548A2 (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO343281B1 (en) * | 2016-12-30 | 2019-01-14 | Aqua Health As | Peptides for the inhibition of trypsin and sea lice infestation. |
| NO343723B1 (en) * | 2016-06-10 | 2019-05-20 | Aqua Health As | Peptides for the inhibition of trypsin and sea lice infestation. |
| NO20211347A1 (en) * | 2021-11-08 | 2023-05-09 | Kapp Det Gode Haap As | Peptides for the inhibition of parasite infection |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006010265A1 (en) * | 2004-07-28 | 2006-02-02 | National Research Council Of Canada | Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| EP2623114A1 (en) * | 2010-09-28 | 2013-08-07 | Centro De Ingenieria Genetica Y Biotecnologia | Vaccine composition for controlling ectoparasite infestations |
-
2012
- 2012-05-17 CA CA2873599A patent/CA2873599A1/en not_active Abandoned
- 2012-05-17 GB GB1421363.1A patent/GB2522119A/en not_active Withdrawn
- 2012-05-17 WO PCT/IB2012/052487 patent/WO2013171548A2/es active Application Filing
-
2013
- 2013-05-16 AR ARP130101697A patent/AR092320A1/es unknown
-
2014
- 2014-12-12 NO NO20141508A patent/NO342822B1/no unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006010265A1 (en) * | 2004-07-28 | 2006-02-02 | National Research Council Of Canada | Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| EP2405003A1 (en) * | 2004-07-28 | 2012-01-11 | National Research Council Of Canada | Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| EP2623114A1 (en) * | 2010-09-28 | 2013-08-07 | Centro De Ingenieria Genetica Y Biotecnologia | Vaccine composition for controlling ectoparasite infestations |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2522119A (en) | 2015-07-15 |
| CA2873599A1 (en) | 2013-11-21 |
| AR092320A1 (es) | 2015-04-15 |
| NO20141508A1 (no) | 2015-02-05 |
| WO2013171548A2 (es) | 2013-11-21 |
| GB201421363D0 (en) | 2015-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Nisbet et al. | Immunity to Haemonchus contortus and vaccine development | |
| Rahman et al. | The outer membrane fraction of Flavobacterium psychrophilum induces protective immunity in rainbow trout and ayu | |
| Li et al. | Protective effects of chicken egg yolk antibody (IgY) against experimental Vibrio splendidus infection in the sea cucumber (Apostichopus japonicus) | |
| US8207132B2 (en) | Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof | |
| US9085634B2 (en) | Vaccine composition for controlling ectoparasite infestations | |
| Yan et al. | Vaccination of goats with DNA vaccine encoding Dim-1 induced partial protection against Haemonchus contortus: A preliminary experimental study | |
| JPH02500799A (ja) | ワクチン | |
| NO342822B1 (no) | Vaksine som induserer en immunrespons mot kopepoder og/eller et slimskjold hos fisk omfattende peptidkombinasjoner, og anvendelse av peptidene for fremstilling av en vaksine. | |
| Frenette et al. | Expression of Interleukin-1β protein in vitro, ex vivo and in vivo salmonid models | |
| US20050281836A1 (en) | Synthetic vaccine for tick control | |
| Hoan et al. | Identification and immunogenicity of microneme protein 2 (EbMIC2) of Eimeria brunetti | |
| WO2016162672A2 (en) | Avian vaccine | |
| Das et al. | Assessment of protective response induced by whole antigens of fish ectoparasite, Argulus siamensis in rohu, Labeo rohita | |
| EP2767290A1 (en) | Amino acid sequences for controlling pathogens | |
| US10105424B2 (en) | Cooperia vaccine | |
| Zhu et al. | Identification and characterization of a cDNA clone-encoding antigen of Eimeria acervulina | |
| DK202170436A1 (en) | Sea Lice Vaccines | |
| CN108727505B (zh) | 一种免疫保护组合蛋白及其免疫疫苗 | |
| US20210061866A1 (en) | Sea lice antigens and vaccines | |
| CN110655564B (zh) | 一种组合蛋白及其应用 | |
| Fereig | Serosurveillance and vaccine development as a strategy for control of Toxoplasma infection | |
| Vericimo et al. | Anisakis | |
| BG99888A (bg) | Приложението на антихелминтни ваксини при лечение на паразитно заболяване,свързано със загуба на естествения имунитет | |
| CUNHA et al. | rROP2 from Toxoplasma gondii as a potential vaccine against oocyst shedding in domestic cats | |
| Selvarayar Arunkumar | Immunoprotection in sheep against Haemonchus contortus using its thiol-purified excretory/secretory proteins. |